Positive allosteric modulation of native and recombinant,γ-aminobutyric acidB receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501

被引:206
作者
Urwyler, S [1 ]
Mosbacher, J [1 ]
Lingenhoehl, K [1 ]
Heid, J [1 ]
Hofstetter, K [1 ]
Froestl, W [1 ]
Bettler, B [1 ]
Kaupmann, K [1 ]
机构
[1] Novartis Pharma AG, TA Nervous Syst, Basel, Switzerland
关键词
D O I
10.1124/mol.60.5.963
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The compounds CGP7930 [2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol] and its close analog CGP13501 were identified as positive modulators of gamma -aminobutyric acid, (GABA(B)) receptor function. They potentiate GABA-stimulated guanosine 5'-O-(3-[S-35]thiotriphosphate) (GTP gamma[S-35]) binding to membranes from a GABA(B(1b/2)) expressing Chinese hamster ovary (CHO) cell line at low micromolar concentrations and are ineffective in the absence of GABA. The structurally related compounds propofol and malonoben are inactive. Similar effects of CGP7930 are seen in a GTP gamma[S-35] binding assay using a native GABA(B) receptor preparation (rat brain membranes). Receptor selectivity is demonstrated because no modulation of glutamate-induced GTP gamma[S-35] binding is seen in a CHO cell line expressing the metabotropic glutamate receptor subtype 2. Dose-response curves with GABA in the presence of different fixed concentrations of CGP7930 reveal an increase of both the potency and maximal efficacy of GABA at the GABA(B(1b/2)) heteromer. Radioligand binding studies show that CGP7930 increases the affinity of agonists but acts at a site different from the agonist binding site. Agonist affinity is not modulated by CGP7930 at homomeric GABA(B(1b)) receptors. In addition to GTP gamma[S-35] binding, we show that CGP7930 also has modulatory effects in cellular assays such as GABA(B) receptor-mediated activation of inwardly rectifying potassium channels in Xenopus laevis oocytes and Ca2+ signaling in human embryonic kidney 293 cells. Furthermore, we show that CGP7930 enhances the inhibitory effect of L-baclofen on the oscillatory activity of cultured cortical neurons. This first demonstration of positive allosteric modulation at GABA(B) receptors may represent a novel means of therapeutic interference with the GABA-ergic system.
引用
收藏
页码:963 / 971
页数:9
相关论文
共 40 条
  • [31] CGP 35348 - A CENTRALLY ACTIVE BLOCKER OF GABA-B RECEPTORS
    OLPE, HR
    KARLSSON, G
    POZZA, MF
    BRUGGER, F
    STEINMANN, M
    VANRIEZEN, H
    FAGG, G
    HALL, RG
    FROESTL, W
    BITTIGER, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (01) : 27 - 38
  • [32] The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan [b]chromen-1α-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors
    Pagano, A
    Rüegg, D
    Litschig, S
    Stoehr, N
    Stierlin, C
    Heinrich, M
    Floersheim, P
    Prezèau, L
    Carroll, F
    Pin, JP
    Cambria, A
    Vranesic, I
    Flor, PJ
    Gasparini, F
    Kuhn, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) : 33750 - 33758
  • [33] Pagano A, 2001, J NEUROSCI, V21, P1189
  • [34] New perspectives for the development of selective metabotropic glutamate receptor ligands
    Pin, JP
    De Colle, C
    Bessis, AS
    Acher, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) : 277 - 294
  • [35] A modulatory effect of extracellular Ca2+ on type 1α metabotropic glutamate receptor-mediated signalling
    Saunders, R
    Nahorski, SR
    Challiss, RAJ
    [J]. NEUROPHARMACOLOGY, 1998, 37 (02) : 273 - 276
  • [36] Novel allosteric antagonists shed light on mglu5 receptors and CNS disorders
    Spooren, WPJM
    Gasparini, F
    Salt, TE
    Kuhn, R
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (07) : 331 - 337
  • [37] Mechanism of synchronized Ca2+ oscillations in cortical neurons
    Wang, XS
    Gruenstein, EI
    [J]. BRAIN RESEARCH, 1997, 767 (02) : 239 - 249
  • [38] Heterodimerization is required for the formation of a functional GABAB receptor
    White, JH
    Wise, A
    Main, MJ
    Green, A
    Fraser, NJ
    Disney, GH
    Barnes, AA
    Emson, P
    Foord, SM
    Marshall, FH
    [J]. NATURE, 1998, 396 (6712) : 679 - 682
  • [39] Calcium sensing properties of the GABAB receptor
    Wise, A
    Green, A
    Main, MJ
    Wilson, R
    Fraser, N
    Marshall, FH
    [J]. NEUROPHARMACOLOGY, 1999, 38 (11) : 1647 - 1656
  • [40] The human GABAB1b and GABAB2 heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen
    Wood, MD
    Murkitt, KL
    Rice, SQ
    Testa, T
    Punia, PK
    Stammers, M
    Jenkins, O
    Elshourbagy, NA
    Shabon, U
    Taylor, SJ
    Gager, TL
    Minton, J
    Hirst, WD
    Price, GW
    Pangalos, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (06) : 1050 - 1054